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Objective. In Japan, the incidence of both colorectal carcinoma and vascular disease is increasing. We screened preoper-
ative patients with abdominal aortic aneurysm (AAA) or peripheral artery disease (PAD) for colorectal cancer.
Design of study. This study was retrospective and cross-sectional.
Materials. The subjects were 492 patients admitted for elective surgery of AAA or PAD.
Methods. The patients underwent immunochemical faecal occult blood tests (FOBT) before operation, and those with
positive results underwent investigations for colorectal neoplasm. We compared the results with that of screening
programmes performed on the general population.
Results. Of the 408 patients that underwent FOBT, 104 (25.5%) were positive. After colonoscopy, six (1.5%) had
colorectal carcinoma and 16 (3.9%) had advanced adenoma. These values were several folds higher than that for the general
population in Japan.
Conclusions. Patients with AAA or PAD carry a high risk for colorectal neoplasm.
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In vascular surgery, the presence of cancer in patients
scheduled to undergo surgery for abdominal aortic
aneurysm (AAA) or peripheral artery disease (PAD)
usually leads to a marked change in the treatment
strategy. In 1994, among the age-adjusted mortality
due to cancer, colorectal cancer (CRC) ranked fourth
in males and second in females in Japan. The inci-
dence of CRC and mortality due to CRC are still
increasing. The incidence of both AAA and PAD is
also increasing due to the increase in atherosclerosis.
In this study, we have focused on CRC because
CRC is an intra-abdominal cancer increasing in the
recent years. We used a noninvasive and a simple
faecal occult blood test (FOBT) for screening, to find
the prevalence of CRC in preoperative vascular
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ing for CRC.
Materials and Methods
During the 7 years from January 1997 to December
2003, 562 patients were admitted to the Department
of Vascular Surgery, The University of Tokyo Hospital
as new patients to undergo surgery for AAA or PAD.
Seventy patients (12.5%) underwent emergency oper-
ation, mainly because of aneurysm rupture or acute
limb ischaemia, and were excluded from the study,
leaving 492 patients who underwent elective surgery.
After approval of the local research ethics commit-
tee and with informed consent, these patients under-
went FOBT soon after admission as preoperative
screening for colorectal lesions. To check faecal occult
blood, immunochemical hemagglutination test has
been adopted in the Laboratory Department of The
University of Tokyo Hospital.1 Those with a positive
test underwent further investigation of the colon
before surgery for AAA or PAD. Barium enema wasrved.
398 K. Yamamoto et al.performed initially, and those with identified lesions
underwent colonoscopy.
Histological classification of colorectal neoplastic
lesions was based on World Health Organization
criteria.2 Advanced adenoma was defined as an ade-
noma with size 10 mm or larger, high-grade dysplasia,
or a villous component of more than 20%. Carcinoma
was defined as malignant cells invading beyond mus-
cularis mucosa. Advanced neoplasia was defined as
both carcinoma and advanced adenoma. Patients
with intramucosal carcinoma or carcinoma in situ
were defined as having adenoma with high-grade
dysplasia. The patients’ records were assessed retro-
spectively. Fisher’s exact test was used to compare
the prevalence between two screening programmes,
and p values below 0.05 were defined as significant.
Results
Of the 492 patients admitted for elective operation for
vascular lesions, 248 had AAA, and 244 had PAD.
Because one aim of the study was to clarify the prev-
alence of colorectal diseases in preoperative patients
with arterial disease, 51 patients with a history of co-
lonic polyp or cancer did not undergo FOBT because
they were already being followed up for colorectal le-
sions. Therefore, they were not enrolled in the study.
This left 441 patients admitted for elective surgery
for arterial lesions, without a history of colorectal neo-
plastic disease. Four hundred and eight of these pa-
tients underwent FOBT. Thirty-three patients were
unable to undergo faecal tests for various reasons
(92.5% screening rate). The baseline characteristics of
408 patients are shown in Table 1. Of the 408 patients
that underwent FOBT, 104 (25.5%) were positive.
There were no differences in the baseline characteris-
tics between the groups with positive or negative
FOBT.
Thirty-seven of the 104 patients with positive
FOBT, did not undergo further study of colorectal le-
sions because of patients refusal or acute worsening of
Table 1. Baseline characteristics of 408 patients that underwent
faecal occult blood test
Age (Mean SD) 70.6 8.7
Sex (Male: Female) 332:76
Hypertension 271 (66.4%)
Diabetes mellitus 122 (29.9%)
Hyperlipidemia 120 (29.4%)
Smoking 332 (81.3%)
History of ischemic heart disease 107 (26.2%)
History of cerbrovascular disease 81 (19.8%)Eur J Vasc Endovasc Surg Vol 33, April 2007the vascular lesion after admission (64.4% surveil-
lance rate).
After further surveillance, which were performed
in 67 patients, 6 were diagnosed as having colorectal
cancer, 16 as having advanced adenoma, three of
which was carcinoma within the mucosal layer, 17
as having other kinds of colorectal polyps and the
remaining 28 had no neoplastic lesions. The results
are shown in Fig. 1. The positive predictive value of
an FOBT for advanced neoplasia was 32.8% (22/67).
Three colon cancer patients underwent open lapar-
atomy for CRC first, followed by vascular surgery,
and one patient underwent open laparotomy for
CRC after vascular surgery. One patient was unable
to undergo surgical treatment of CRC because of dis-
tant metastasis to the lungs and liver. The remaining
patients with CRC or adenoma had their colorectal
lesions resected endoscopically.
Discussion
FOBT is a simple non-invasive test to detect colorectal
neoplasm. In randomized controlled trials, FOBT has
been shown to reduce mortality from colorectal cancer
by 15e33%, and since then FOBT has been established
as a screening test.3e5 Although a recent study dem-
onstrated sigmoidoscopy to be more effective than
FOBT, it is not yet feasible for population based
screening or preoperative screening before vascular
surgery in Japan.6 In Japan, cases of positive FOBT
are reported to comprise 7.3% of the population,
and cases of CRC, including those limited to the mu-
cosal layer, were found in 0.15% of the population.7
In our study, if we include intramucosal carcinoma
as colorectal carcinoma, another three patients
with advanced adenoma would be considered to
have colorectal carcinoma, resulting in a CRC rate of
2.2%.
In our study, if we use the number of patients un-
dergoing FOBT (408 patients) as a denominator,
25.5% had a positive FOBT, 1.5% had colorectal carci-
noma, and 5.4% had advanced neoplasia (Table 2). 8
These values were all significantly higher in our study
(P< 0.001 for positive FOBT, 0.0048 for CRC and 0.02
for advanced neoplasia).
Exclusion of 37 patients (36%) may bias interpreta-
tion of the data, but we have used 408 patient as the
baseline population on a intention to treat basis, and
therefore, the prevalence of advanced neoplasia and
CRC may become higher but not lower.
There are some possible explanations for this high
rate of advanced neoplasm in preoperative vascular dis-
ease patients. First, there is a possibility that vascular
399High CRC in Patients before Vascular SurgeryFig. 1. Flow chart showing the results of colorectal screening in patients before vascular surgery.patients are of older age because the incidence ofmost of
the neoplasm is known to increase with age. Although
agedistribution inMorikawa’s study is not defined, Seg-
nan’s study only included those aged 55e64, and if we
restricted thepatients in this study to55e64years (78pa-
tients), the positive FOBT rate was 29% and advanced
neoplasia rate was 7.7% which was still higher than
that reported by Segnan (4.3% and 1.7% respectively).6
Second, there was a large difference in sex ratio.
Morikawa’s study included 6111 females (28.0%),
whereas our study included only 76 (18.6%) because
of the high male prevalence of vascular disease. Al-
though there was no significant difference in the
rate of positive FOBT and advanced neoplasia in our
study (male vs. female: 24.7% vs. 29.0% for positive
FOBT, 5.1% vs. 6.6% for advanced neoplasia), this
may be the result of the low number of patients.
The presence of colorectal lesions may change the
strategy for treating vascular lesion for a number of
reasons. First, there is a problem in the order of sur-
gery if both colorectal lesion and vascular lesion
Table 2. Comparison of the results of faecal occult blood test
(FOBT), between present study and a general screening test in
Japan
Present study
(n¼ 408)
Morikawa8
(n¼ 21805)
P value
Sex (Male) 336(82.4%) 15694(72.0%)
Mean age 70.6 8.7 48.2 9.3
Positive FOBT 104(25.5%) 1231(5.6%) <0.0001
Colorectal
carcinoma
6(1.5%) 79(0.4%) 0.0048
Advanced
neoplasia
22(5.4%) 727(3.3%) 0.02such as AAA or aorto-iliac occlusive disease require
open laparotomy. There are many studies concerning
the treatment of simultaneous disease, and although
no standard has been established regarding the issue,
it is important to perform the surgery safely, decreas-
ing the possibility of life-threatening complications.
Second, although PAD of lower limb may not involve
laparotomy, patients are likely to receive anticoagula-
tion and anti-platelet therapy after revascularization,
and this may lead to bleeding and anaemia in the
presence of colorectal cancer or polyps.
Incidence of CRC in patients with AAA is reported
to be 0.5 to 4.6%,9e16 and to our knowledge, there are
no reports on CRC prevalence in patients with PAD.
These values include vascular lesions found inciden-
tally during a survey of known CRC, and therefore
the actual incidence of CRC may be lower. In our
study, the prevalence of CRC in patients with AAA
or PAD was 1.5%. Considering that the screening
rate was 92.5% and the surveillance rate was 64.4%,
the actual prevalence of CRC and adenoma could be
higher than the results obtained in this study. As
with other studies regarding screening programmes,
an increase in screening and surveillance rates in-
creases the benefit of the screening itself.
Whatever screening method we choose, we are
sure that preoperative patients for vascular surgery
have high risks for CRC. Unfortunately, we were un-
able to follow up the patients with negative FOBT,
regarding cancer. Therefore, the true sensitivity and
specificity of FOBT cannot be calculated, and its supe-
riority over other screening methods is not known.
In conclusion, preoperative vascular disease pa-
tients with AAA or PAD have a high risk for colorectalEur J Vasc Endovasc Surg Vol 33, April 2007
400 K. Yamamoto et al.neoplasm. Screening should be considered in these
patients.
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